Navigation Links
ViroPharma to Release 2010 Fourth Quarter and Full Year Financial Results on February 24, 2011
Date:2/10/2011

EXTON, Pa., Feb. 10, 2011 /PRNewswire/ -- ViroPharma Incorporated's (Nasdaq: VPHM) fourth quarter and year end financial results for 2010 are expected to be released on Thursday, February 24, 2011 before the open of the U.S. financial markets.

The company will host a conference call and live audio webcast at 9:00 a.m. Eastern Time on the same day.  During the conference call, ViroPharma management will discuss the 2010 fourth quarter and full year financial results and other business.

The press release and the live webcast of the conference call will be accessible via ViroPharma's corporate website at http://www.viropharma.com.  An audio archive will be available at the same address until March 18, 2011.  To participate in the conference call, please dial (888) 299-4099 (domestic) and (302) 709-8337 (international).  After placing the call, please tell the operator you wish to join the ViroPharma investor conference call.  

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products for physician specialists to enable the support of patients with serious diseases for which there is an unmet medical need, and providing rewarding careers to employees.  ViroPharma commercializes Cinryze® (C1 esterase inhibitor [human]) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE).  ViroPharma commercializes Vancocin®, approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information on ViroPharma's commercial
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ViroPharma to Participate in Several Upcoming Healthcare Investor Conferences
2. ViroPharma Receives Complete Response Letter for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
3. ViroPharma to Release 2010 Third Quarter Financial Results on October 27, 2010
4. ViroPharma to Present at the Jefferies 2010 Global Healthcare Conference
5. ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study
6. ViroPharma To Participate in Two September Healthcare Investor Conferences
7. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
8. ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing
9. ViroPharma to Participate in Two June Healthcare Investor Conferences
10. ViroPharma To Host Investor Day
11. ViroPharma to Participate in the Cowen and Company 30th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 2014 Luoxis Diagnostics, Inc., a subsidiary ... announced the presentation of three clinical and preclinical ... broadly applicable and robust research tool capable of ... response to injury, illness, or stress.  In all ... Luoxis, academic and pharmaceutical research partners, RedoxSYS was ...
(Date:11/24/2014)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... today that Sergio Traversa , chief executive officer, ... Event" Micro-Cap Growth Conference on Wednesday, December 3, 2014.  ... Bel Air Hotel, which is located at 11461 Sunset ... The presentation is scheduled for 8:30 a.m. ...
(Date:11/24/2014)... , Nov. 24, 2014  AiCure, an ... motion-sensing technology to monitor medication ingestion, has announced ... monitor and intervene with patients receiving medication as ... Fatal overdoses from prescription opiates have quadrupled in ... deaths per year than heroin, cocaine and benzodiazepines ...
Breaking Medicine Technology:Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 2Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 4Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 5Relmada Therapeutics To Present At LD MICRO Conference 2Can artificial intelligence solve the $55 billion problem of opioid abuse? 2
... MALVERN, Pa., Nov. 17, 2010 Siemens ... System is now commercially available in the United ... diagnostic mammography, stereotactic biopsy, and upgrade capability to ... (Logo: http://photos.prnewswire.com/prnh/20070904/SIEMENSLOGO ) ...
... The National Community Pharmacists Association (NCPA) ... to unite to host what the organizers are calling ... the eastern Suffolk area of New York. ... ) According to event organizer and NCPA ...
Cached Medicine Technology:Siemens MAMMOMAT Inspiration Digital Mammography Commercially Available in U.S. 2Siemens MAMMOMAT Inspiration Digital Mammography Commercially Available in U.S. 3NCPA Commends Prescription Drug Take Back Event Hosted by 15 New York Pharmacies 2NCPA Commends Prescription Drug Take Back Event Hosted by 15 New York Pharmacies 3
(Date:11/24/2014)... November 24, 2014 Global electrophysiology ... billion by 2020, according to a new study ... of cardiac arrhythmias clubbed with growing global geriatric ... market. Though still in the budding stage, the ... in usage rates in the recent times, with ...
(Date:11/24/2014)... Residents of retirement communities in Ohio ... SENIORS GOT TALENT, an annual online talent competition and ... to classic crooners, to seniors partying on a “night ... indeed living young. , “SENIORS GOT TALENT, while still ... prize, has always been about highlighting the vibrancy of ...
(Date:11/24/2014)... The Holiday Inn Westbury - Long ... Children's Association to donate various items consisting of ... other such items.The Association's program is aimed toward helping ... in nursing homes, assisted living facilities and nursing homes. ... being of seniors throughout the Long Island area. The ...
(Date:11/24/2014)... CA (PRWEB) November 24, 2014 SafeHandles™ ... episode of Innovations with Ed Begley Jr, airing via ... was created to provide a passive, non-invasive, replaceable, and ... how SafeHandles™ incorporates custom-fit shrinkable sleeves and adhesives to ... , “At the core of SafeHandles is the ...
(Date:11/24/2014)... PA (PRWEB) November 24, 2014 "My ... he was trying to cross the street in his ... driver never saw him. I came up with this ... visible at night." , He developed the Safety Lites ... or in low-lighting conditions. The device ensures that motorists ...
Breaking Medicine News(10 mins):Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 2Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 3Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 4Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 2Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 3Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2
... Therapeutic Focus Through ... Extending the Good Baby Product Line, ... (Nasdaq: BJGP; "BMP Sunstone"; the "Company") today,announced that its ... a non-binding letter of,intent to acquire 75 percent of ...
... babies born with hearing loss, experts note , , FRIDAY, July ... that all newborns be screened for congenital hearing loss. , ... infant,s health care evaluation," U.S. Preventive Services Task Force Chairman ... Colorado Department of Public Health and Environment, said in a ...
... is a Patient Education System that provides hospitals, medical centers and ... accessible using a telephone, pillow speaker, interactive touch screen or computer. ... ... Synergy Broadcast Systems recently launched several new interface options to it's ...
... Ky., July 17 William F. McMurry, a,Nationally ... obtained today final Court approval of a settlement ... by a Kentucky state court,judge. The settlement gives ... of deferred annuities. The Settlement is valued at ...
... Governor,Schwarzenegger and regulators announced a company-friendly settlement ... new lawsuit filed by the Los Angeles,City Attorney ... retroactively,canceling policies when patients got sick. Today,s settlement ... $5 million penalty., "The timing of today,s ...
... GlycoMark(R) Blood Test Now Established to Provide Physicians with Vital ... ... Patients with Diabetes, NEW YORK and WINSTON-SALEM, N.C., July ... Co., Ltd. (Tokyo, Japan),announced today the formation of a new joint ...
Cached Medicine News:Health News:BMP Sunstone Signs Letter of Intent to Acquire Shengda Pharmaceutical Co. 2Health News:BMP Sunstone Signs Letter of Intent to Acquire Shengda Pharmaceutical Co. 3Health News:All Newborns Should Have Ears Screened, Task Force Says 2Health News:Synergy Broadcast Systems Announces Enhancements to MMDS Patient Education System 2Health News:Synergy Broadcast Systems Announces Enhancements to MMDS Patient Education System 3Health News:William F. McMurry - Lead Class Counsel Obtains $16.4 Million Settlement for Elderly Clients 2Health News:Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes 2Health News:Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes 3
50L...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
Medicine Products: